Hishikawa Tomohito, Ono Shigeki, Ogawa Tomoyuki, Tokunaga Koji, Sugiu Kenji, Date Isao
Department of Neurological Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
Neurosurgery. 2008 Jan;62(1):232-40; discussion 240-1. doi: 10.1227/01.NEU.0000311082.88766.33.
Hypoxia-inducible factor (HIF)-1 is a transcription factor that regulates the expression of various neuroprotective genes. The goal of this study was to clarify the relationship between HIF-1 expression and subarachnoid hemorrhage (SAH) and to characterize the effects of deferoxamine (DFO)-induced increases in HIF-1 protein levels on the brainstem and the basilar artery (BA) after experimental SAH.
Rat single- and double-hemorrhage models (injected on Days 0 and 2) of SAH were used. We assessed the time courses for HIF-1 protein levels in the brainstems and the BA diameters within 10 minutes and 6 hours on Days 1 and 2 in the single-SAH model, and also on Day 7 in the double-SAH model. After induction of double hemorrhage in rats, DFO was injected intraperitoneally. We then evaluated HIF-1 protein expression and brainstem activity, BA diameter, and brainstem blood flow.
After the rats experienced SAH, HIF-1 protein expression was significantly greater at 10 minutes in the single-injection model and at 7 days in the double-injection model than at similar time points in the control group, and these increases correlated with degrees of cerebral vasospasm. DFO injection resulted in significant increases in HIF-1 protein expression and activity in the brainstems of rats with SAH, compared with the rats with SAH that were given placebos, and the rats without SAH in the double-hemorrhage model. Cerebral vasospasm and reduction of brainstem blood flow were significantly attenuated in the rats that were administered DFO.
These results show that a DFO-induced increase in HIF-1 protein level and activity exerts significant attenuation of BA vasospasm and reduction of brainstem blood flow in the rat model of SAH. DFO may be a promising agent for treating clinical SAH.
缺氧诱导因子(HIF)-1是一种调节多种神经保护基因表达的转录因子。本研究的目的是阐明HIF-1表达与蛛网膜下腔出血(SAH)之间的关系,并描述去铁胺(DFO)诱导的HIF-1蛋白水平升高对实验性SAH后脑干和基底动脉(BA)的影响。
采用大鼠SAH单出血和双出血模型(分别于第0天和第2天注射)。我们评估了单SAH模型中第1天和第2天10分钟和6小时时脑干中HIF-1蛋白水平的时间进程以及BA直径,双SAH模型中第7天时的情况也进行了评估。在大鼠诱导双次出血后,腹腔注射DFO。然后我们评估HIF-1蛋白表达、脑干活性、BA直径和脑干血流。
大鼠发生SAH后,单注射模型中10分钟时以及双注射模型中7天时的HIF-1蛋白表达明显高于对照组的相似时间点,且这些升高与脑血管痉挛程度相关。与给予安慰剂的SAH大鼠以及双出血模型中未发生SAH的大鼠相比,注射DFO导致SAH大鼠脑干中HIF-1蛋白表达和活性显著增加。给予DFO的大鼠脑血管痉挛和脑干血流减少明显减轻。
这些结果表明,DFO诱导的HIF-1蛋白水平和活性增加可显著减轻SAH大鼠模型中的BA血管痉挛和脑干血流减少。DFO可能是治疗临床SAH的一种有前景的药物。